Being invited to present at Clinical Accelerator’s Georgia Medtech Innovation Summit 2026 is certainly an opportunity when clinical phase is on the horizon.
CEO, Daniele Zanotti, took the stage on September 11 to share the latest updates about TriClover since StarTric’s last time in Tbilisi. To date, preclinical data about TriClover’s performance and safety profile support the company’s steady journey toward clinical validation.
StarTric had a dedicated booth at the summit and the team enjoyed reconnecting with a community known for its strong hands-on experience in First-In-Human trials and discussing TriClover’s path forward.
